Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-Induced Hypertension.

Matthew C Foy1, Joban Vaishnav2, Christopher John Sperati3

  • 1Division of Nephrology, Louisiana State University Health Science Center, 5246 Brittany Dr, Baton Rouge, LA 70808, USA.

Endocrinology and Metabolism Clinics of North America
|October 28, 2019
PubMed
Summary

Many common medications can cause or worsen high blood pressure (hypertension) through various mechanisms like fluid retention. Recognizing these drug-induced hypertension causes is key for effective blood pressure management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Human iPSC-based Microphysiogical Models of Transthyretin Amyloid Cardiomyopathy.

Research square·2026
Same author

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
Same author

Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes.

Journal of cardiac failure·2026
Same author

If You Build It, They Will Come: Early Career Reflections on Developing a Clinical Niche.

Journal of cardiac failure·2026
Same author

Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art Review.

JACC. CardioOncology·2026
Same author

Clinical and imaging profiling of restrictive cardiomyopathies: insights into amyloid, sarcoid, and iron overload phenotypes.

Heart failure reviews·2026

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Clinical Pharmacy

Background:

  • Untoward pharmaceutical side effects contribute significantly to morbidity and healthcare costs.
  • A notable portion of the hypertensive population may have drug-induced hypertension due to polypharmacy.
  • Drug-induced hypertension presents a significant challenge in managing blood pressure effectively.

Purpose of the Study:

  • To discuss the epidemiology, pathophysiology, and management of drug-induced hypertension.
  • To highlight common medications implicated in causing or exacerbating high blood pressure.
  • To inform healthcare providers on recognizing and addressing medication-related hypertension.

Main Methods:

  • Review of existing literature on drug-induced hypertension.
Keywords:
Drug-induced hypertensionPolypharmacySecondary hypertension

Related Experiment Videos

  • Analysis of mechanisms leading to elevated blood pressure from medications.
  • Discussion of epidemiological data and clinical management strategies.

    • Main Results:

    • Polypharmacy is a likely contributor to hypertension in a substantial patient group.
    • Mechanisms include sodium/fluid retention, renin-angiotensin-aldosterone system activation, and altered vascular tone.
    • Identification of specific drug classes associated with hypertension is crucial.

    Conclusions:

    • Effective blood pressure control necessitates the recognition of drug-induced hypertension.
    • Understanding the pathophysiology aids in diagnosing and managing medication-related blood pressure elevation.
    • Clinical awareness of causative agents is paramount for patient care.